Open AccessCOL3A1 Overexpression Associates with Poor Prognosis and Cisplatin Resistance in Lung Cancer
Author(s) -
Lihuai Wang,
Yifeng Sun,
Zhongcong Guo,
Hua Liu
Publication year - 2022
Publication title -
balkan medical journal/balkan medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 16
eISSN - 2146-3131
pISSN - 2146-3123
DOI - 10.4274/balkanmedj.galenos.2022.2022-6-16
Subject(s) - cisplatin , lung cancer , downregulation and upregulation , apoptosis , clone (java method) , cancer research , adenocarcinoma , cell growth , biology , viability assay , cell , cell culture , cancer , gene , medicine , oncology , chemotherapy , genetics
Collagen type III alpha 1 chain (COL3A1) is reported to mediate drug resistance in various cancers, and public database analysis indicated its overexpression in lung cancer.